{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:18:19Z","timestamp":1792451899108,"version":"4.5.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T00:00:00Z","timestamp":1317945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0026077","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T22:05:39Z","timestamp":1318025139000},"page":"e26077","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":160,"title":["mGluR5-Antagonist Mediated Reversal of Elevated Stereotyped, Repetitive Behaviors in the VPA Model of Autism"],"prefix":"10.1371","volume":"6","author":[{"given":"Mili V.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Gandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archgenpsychiatry.2011.38","article-title":"Epidemiology of autism spectrum disorders in adults in the community in England.","volume":"68","author":"TS Brugha","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","article-title":"Prevalence of Autism Spectrum Disorders in a Total Population Sample.","author":"YS Kim","year":"2011"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(09)61376-3","article-title":"Autism.","volume":"374","author":"SE Levy","year":"2009","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10803-006-0332-6","article-title":"Restricted and repetitive behaviors in young children with autism spectrum disorders.","volume":"37","author":"J Richler","year":"2007","journal-title":"J Autism Dev Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.","volume":"66","author":"BH King","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","article-title":"Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.","volume":"162","author":"CJ McDougle","year":"2005","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1744-6171.2007.00112.x","article-title":"Risperidone approved for the treatment of serious behavioral problems in children with autism.","volume":"20","author":"L Scahill","year":"2007","journal-title":"J Child Adolesc Psychiatr Nurs"},{"key":"ref8","article-title":"Risperidone for the core symptom domains of autism.","volume":"551-552","author":"B Adetunji","year":"2006","journal-title":"Am J Psychiatry 163: 551; author reply"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005040.pub2","article-title":"Risperidone for autism spectrum disorder.","author":"OS Jesner","year":"2007"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.med.60.053107.121225","article-title":"Advances in autism.","volume":"60","author":"DH Geschwind","year":"2009","journal-title":"Annu Rev Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pedhc.2008.12.001","article-title":"Pharmacologic treatment for the core deficits and associated symptoms of autism in children.","volume":"23","author":"L West","year":"2009","journal-title":"J Pediatr Health Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","article-title":"A systematic review of medical treatments for children with autism spectrum disorders.","volume":"127","author":"ML McPheeters","year":"2011","journal-title":"Pediatrics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder.","volume":"47","author":"AD Rasalam","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs.","volume":"71","author":"RL Bromley","year":"2008","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","article-title":"Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism.","volume":"68","author":"MJ Gandal","year":"2010","journal-title":"Biol Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.","volume":"30","author":"T Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems.","volume":"2","author":"JL Rubenstein","year":"2003","journal-title":"Genes Brain Behav"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11689-009-9023-x","article-title":"Common circuit defect of excitatory-inhibitory balance in mouse models of autism.","volume":"1","author":"N Gogolla","year":"2009","journal-title":"J Neurodev Disord"},{"key":"ref19","article-title":"Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders.","author":"GC Carlson","year":"2011"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1523\/JNEUROSCI.4517-09.2010","article-title":"Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.","volume":"30","author":"J Blundell","year":"2010","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.","volume":"35","author":"JL Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01935-6","article-title":"In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine).","volume":"473","author":"JJ Anderson","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature09965","article-title":"Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.","volume":"472","author":"J Peca","year":"2011","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","article-title":"Behavioural phenotyping assays for mouse models of autism.","volume":"11","author":"JL Silverman","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety.","volume":"204","author":"A Thomas","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism.","volume":"33","author":"K Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","article-title":"Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.","volume":"31","author":"FM de Vrij","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","article-title":"Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome.","volume":"45","author":"SM McBride","year":"2005","journal-title":"Neuron"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/jpet.109.154138","article-title":"The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine.","volume":"330","author":"MC Montana","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.","volume":"49","author":"QJ Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08990220601179418","article-title":"Tactile sensitivity of normal and autistic children.","volume":"24","author":"B Guclu","year":"2007","journal-title":"Somatosensory & motor research"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2011.03.052","article-title":"Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism.","author":"MA Bangash","year":"2011"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.","volume":"104","author":"T Rinaldi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/neuro.01.1.1.006.2007","article-title":"The intense world syndrome\u2013an alternative hypothesis for autism.","volume":"1","author":"H Markram","year":"2007","journal-title":"Front Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2009.12.042","article-title":"Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition.","volume":"639","author":"H Homayoun","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nurx.2005.12.006","article-title":"Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.","volume":"3","author":"C Pittenger","year":"2006","journal-title":"NeuroRx"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cpr.2004.04.004","article-title":"Obsessing\/worrying about the overlap between obsessive-compulsive disorder and generalized anxiety disorder in youth.","volume":"24","author":"JS Comer","year":"2004","journal-title":"Clin Psychol Rev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors.","volume":"10","author":"JN Crawley","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1750-3639.2007.00096.x","article-title":"Mouse behavioral assays relevant to the symptoms of autism.","volume":"17","author":"JN Crawley","year":"2007","journal-title":"Brain Pathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbr.2007.10.029","article-title":"Development of a mouse test for repetitive, restricted behaviors: relevance to autism.","volume":"188","author":"SS Moy","year":"2008","journal-title":"Behav Brain Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1601-183X.2010.00659.x","article-title":"Motor and cognitive stereotypies in the BTBR T+tf\/J mouse model of autism.","volume":"10","author":"BL Pearson","year":"2011","journal-title":"Genes Brain Behav"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbr.2006.08.023","article-title":"Animal models of restricted repetitive behavior in autism.","volume":"176","author":"MH Lewis","year":"2007","journal-title":"Behav Brain Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2004.11.010","article-title":"Contrasting grooming phenotypes in three mouse strains markedly different in anxiety and activity (129S1, BALB\/c and NMRI).","volume":"160","author":"AV Kalueff","year":"2005","journal-title":"Behav Brain Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(86)90051-8","article-title":"Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice.","volume":"126","author":"CL Broekkamp","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0896-6273(01)00564-5","article-title":"Hoxb8 is required for normal grooming behavior in mice.","volume":"33","author":"JM Greer","year":"2002","journal-title":"Neuron"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0091-3057(02)00828-6","article-title":"Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone.","volume":"73","author":"J Brodkin","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0022-3565(24)39029-9","article-title":"Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.","volume":"295","author":"WP Spooren","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.","volume":"29","author":"CS Busse","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.","volume":"132","author":"E Tatarczynska","year":"2001","journal-title":"Br J Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0026077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:20:39Z","timestamp":1741796439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0026077"}},"subtitle":[],"editor":[{"given":"Melissa","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,7]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0026077","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,7]]}}}